Laura is a Research Fellow within the Centre for Health Economics, Monash University, and an Honorary Research Fellow at the Research Department of Practice and Policy, School of Pharmacy, University College London. Her qualifications include BPharm(Hons), MPH, PhD. She has extensive expertise in health economic evaluation, pharmacoepidemiology, health technology assessment and in the linkage and analysis of population-based healthcare data from Australian and international healthcare settings (United Kingdom and Hong Kong).

She evaluates the clinical- and cost-effectiveness of pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and conducts independent research into the comparative effectiveness, safety and value for money of pharmaceuticals in real-world populations. In her work, Laura undertakes epidemiological and economic modelling, and economic evaluations alongside clinical trials. Her research spans several chronic diseases, including atrial fibrillation, dementia and haematological malignancies. She has recently received competitively awarded research funding from the Medical Research Future Fund and The Australian Digital Health Agency.

Health Economic Evaluation

Economics of pharmaceuticals

Pharmacoepidemiology

Health Technology Assessment